ALLOW- EVALUATION OF ABATACEPT ADMINISTERED SUBCUTANEOUSLY IN ADULTS WITH ACTIVE RHEUMATOID ARTHRITIS; IMPACT OF WITHDRAWAL AND REINTRODUCTION ON IMMUNOGENICITY, EFFICACY AND SAFETY
Mark Identification

ALLOW- EVALUATION OF ABATACEPT ADMINISTERED SUBCUTANEOUSLY IN ADULTS WITH ACTIVE RHEUMATOID ARTHRITIS; IMPACT OF WITHDRAWAL AND REINTRODUCTION ON IMMUNOGENICITY, EFFICACY AND SAFETY

Serial Number

85164758

Filing Date

Oct 29, 2010

Trademark by

BRISTOL-MYERS SQUIBB COMPANY

Classification Information

Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use

Computer and Scientific